Company Search:
Advanced Search
Sponsored Links
Boiron SA Company Snapshot
Boiron SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Boiron SA with three other companies in this sector in France: Vetoquinol Sa (2016 sales of 350.35 million Euro [US$429.36 million] of which 76% was Europe), Virbac (871.83 million Euro [US$1.07 billion] of which 58% was Companion Animals), and Guerbet SA (775.77 million Euro [US$950.70 million] of which 48% was X-rays).

Sales Analysis. During the year ended December of 2016, sales at Boiron SA were 614.49 million Euro (US$753.05 million). This is a very small increase of 1.1% versus 2015, when the company's sales were 607.80 million Euro. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 393.9% in 2016, from 294,000.00 Euro to 1.45 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Boiron SA
  Stock Performance Chart for Boiron SA
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 77.20
(Figures in Euro)
1 Week 2.4%   13 Weeks 5.4%  
4 Weeks 0.2%   52 Weeks -10.0%  
Boiron SA Key Data:
  Ticker: BOI Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 614,489,000
(Year Ending Jan 2017).
Employees: 3,708
  Currency: Euro Market Cap: 1,422,445,512
  Fiscal Yr Ends: December Shares Outstanding: 18,425,460
  Share Type: Actions Ordinaries Closely Held Shares: 13,091,364
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.